Norinchukin Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.75M | Buy |
127,822
+230
| +0.2% | +$13.4K | 0.09% | 128 |
|
|
2025
Q4 | $6.88M | Buy |
127,592
+8,571
| +7% | +$412K | 0.08% | 138 |
|
|
2025
Q3 | $5.37M | Buy |
119,021
+3,394
| +3% | +$159K | 0.07% | 151 |
|
|
2025
Q2 | $5.35M | Buy |
115,627
+4,075
| +4% | +$200K | 0.08% | 151 |
|
|
2025
Q1 | $6.8M | Buy |
111,552
+15,561
| +16% | +$907K | 0.13% | 116 |
|
|
2024
Q4 | $5.43M | Buy |
95,991
+10,055
| +12% | +$562K | 0.11% | 114 |
|
|
2024
Q3 | $4.45M | Buy |
85,936
+13,197
| +18% | +$619K | 0.11% | 126 |
|
|
2024
Q2 | $3.02M | Buy |
72,739
+1,378
| +2% | +$61.7K | 0.09% | 137 |
|
|
2024
Q1 | $3.87M | Sell |
71,361
-1,023
| -1% | -$52.1K | 0.12% | 118 |
|
|
2023
Q4 | $3.71M | Sell |
72,384
-10,175
| -12% | -$534K | 0.09% | 117 |
|
|
2023
Q3 | $4.79M | Sell |
82,559
-104,449
| -56% | -$6.4M | 0.11% | 96 |
|
|
2023
Q2 | $12M | Buy |
187,008
+46,265
| +33% | +$3.1M | 0.2% | 86 |
|
|
2023
Q1 | $9.75M | Buy |
140,743
+4,118
| +3% | +$290K | 0.19% | 79 |
|
|
2022
Q4 | $9.83M | Sell |
136,625
-35,741
| -21% | -$2.69M | 0.21% | 75 |
|
|
2022
Q3 | $12.3M | Buy |
172,366
+21,023
| +14% | +$1.53M | 0.25% | 68 |
|
|
2022
Q2 | $11.7M | Sell |
151,343
-51,839
| -26% | -$3.95M | 0.23% | 71 |
|
|
2022
Q1 | $14.8M | Buy |
203,182
+12,406
| +7% | +$833K | 0.2% | 81 |
|
|
2021
Q4 | $11.9M | Sell |
190,776
-1,420
| -0.7% | -$83.3K | 0.15% | 97 |
|
|
2021
Q3 | $11.4M | Buy |
192,196
+7,353
| +4% | +$484K | 0.16% | 96 |
|
|
2021
Q2 | $12.4M | Sell |
184,843
-1,515
| -0.8% | -$98.8K | 0.18% | 85 |
|
|
2021
Q1 | $11.8M | Buy |
186,358
+1,414
| +0.8% | +$88K | 0.16% | 82 |
|
|
2020
Q4 | $11.5M | Sell |
184,944
-5,474
| -3% | -$337K | 0.16% | 80 |
|
|
2020
Q3 | $11.5M | Buy |
190,418
+965
| +0.5% | +$58.1K | 0.18% | 73 |
|
|
2020
Q2 | $11.1M | Sell |
189,453
-8,779
| -4% | -$525K | 0.19% | 71 |
|
|
2020
Q1 | $11M | Sell |
198,232
-182,350
| -48% | -$11.1M | 0.22% | 65 |
|
|
2019
Q4 | $24.4M | Buy |
380,582
+94,455
| +33% | +$5.41M | 0.32% | 58 |
|
|
2019
Q3 | $14.5M | Buy |
286,127
+6,314
| +2% | +$297K | 0.2% | 83 |
|
|
2019
Q2 | $12.7M | Sell |
279,813
-114,571
| -29% | -$5.34M | 0.19% | 78 |
|
|
2019
Q1 | $18.8M | Buy |
394,384
+11,207
| +3% | +$558K | 0.24% | 79 |
|
|
2018
Q4 | $19.9M | Buy |
383,177
+89,338
| +30% | +$4.8M | 0.28% | 64 |
|
|
2018
Q3 | $18.2M | Buy |
293,839
+24,132
| +9% | +$1.43M | 0.25% | 72 |
|
|
2018
Q2 | $14.9M | Buy |
269,707
+35,690
| +15% | +$1.93M | 0.22% | 81 |
|
|
2018
Q1 | $14.8M | Buy |
234,017
+19,461
| +9% | +$1.25M | 0.25% | 69 |
|
|
2017
Q4 | $13.1M | Buy |
214,556
+8,539
| +4% | +$534K | 0.23% | 77 |
|
|
2017
Q3 | $13.1M | Buy |
206,017
+6,935
| +3% | +$405K | 0.25% | 69 |
|
|
2017
Q2 | $11.1M | Buy |
199,082
+4,708
| +2% | +$256K | 0.23% | 73 |
|
|
2017
Q1 | $10.6M | Buy |
194,374
+8,154
| +4% | +$447K | 0.23% | 70 |
|
|
2016
Q4 | $10.9M | Buy |
186,220
+12,430
| +7% | +$680K | 0.25% | 64 |
|
|
2016
Q3 | $9.37M | Buy |
173,790
+1,732
| +1% | +$111K | 0.23% | 66 |
|
|
2016
Q2 | $12.7M | Buy |
172,058
+2,254
| +1% | +$159K | 0.31% | 54 |
|
|
2016
Q1 | $10.8M | Sell |
169,804
-8,497
| -5% | -$536K | 0.26% | 61 |
|
|
2015
Q4 | $12.3M | Sell |
178,301
-33,915
| -16% | -$2.24M | 0.31% | 48 |
|
|
2015
Q3 | $12.6M | Buy |
212,216
+1,130
| +0.5% | +$71.7K | 0.33% | 46 |
|
|
2015
Q2 | $14M | Sell |
211,086
-3,584
| -2% | -$236K | 0.36% | 41 |
|
|
2015
Q1 | $13.8M | Sell |
214,670
-13,139
| -6% | -$823K | 0.33% | 44 |
|
|
2014
Q4 | $13.4M | Buy |
227,809
+31,724
| +16% | +$1.79M | 0.33% | 41 |
|
|
2014
Q3 | $10M | Buy |
196,085
+4,748
| +2% | +$237K | 0.29% | 46 |
|
|
2014
Q2 | $9.28M | Sell |
191,337
-16,361
| -8% | -$806K | 0.27% | 46 |
|
|
2014
Q1 | $10.8M | Buy |
207,698
+13,271
| +7% | +$706K | 0.31% | 45 |
|
|
2013
Q4 | $10.3M | Sell |
194,427
-637
| -0.3% | -$32.4K | 0.28% | 46 |
|
|
2013
Q3 | $9.03M | Buy |
195,064
+5,532
| +3% | +$243K | 0.26% | 48 |
|
|
2013
Q2 | $8.47M | Buy |
+189,532
| New | +$8.23M | 0.26% | 46 |
|
Other funds holding BMY
VCM
VPM
Norinchukin Bank's BMY Position: Q1 2026 in Review
Norinchukin Bank increased its Bristol-Myers Squibb (BMY) stake by 0.18% in Q1 2026, buying an estimated $13.4K and bringing the position to 127,822 shares worth $7.75M. The position accounts for 0.09% of the portfolio, ranked #128.
Norinchukin Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.4M in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Norinchukin Bank held 127,822 shares of Bristol-Myers Squibb worth $7.75M as of Q1 2026.
- Norinchukin Bank bought 230 Bristol-Myers Squibb shares in Q1 2026, an estimated $13.4K.
- Bristol-Myers Squibb made up 0.09% of Norinchukin Bank's portfolio in Q1 2026, its #128 holding.
- Norinchukin Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Norinchukin Bank's Bristol-Myers Squibb position peaked at $24.4M in Q4 2019.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Norinchukin Bank's 13F filing for Q1 2026, filed 15 May 2026.